Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Anticancer Research|December 30, 2025
P53-Armed Oncolytic Virotherapy Promotes the Efficacy of PD1 Blockade in Murine Osteosarcoma TumorsMiho Kure, Hiroshi Tazawa, Koji Demiya, et al.
Frontiers in Digital Health|March 12, 2025
Empowering pediatric, adolescent, and young adult patients with cancer utilizing generative AI chatbots to reduce psychological burden and enhance treatment engagement: a pilot studyJoe Hasei, Mana Hanzawa, Akihito Nagano, et al.
Cancer Science|September 2, 2024
High-quality expert annotations enhance artificial intelligence model accuracy for osteosarcoma X-ray diagnosisJoe Hasei, Ryuichi Nakahara, Yujiro Otsuka, et al.
Cancers|January 11, 2025
The Three-Class Annotation Method Improves the AI Detection of Early-Stage Osteosarcoma on Plain Radiographs: A Novel Approach for Rare Cancer DiagnosisJoe Hasei, Ryuichi Nakahara, Yujiro Otsuka, et al.
Scientific Reports|November 9, 2017
Circulating MicroRNA-92b-3p as a Novel Biomarker for Monitoring of Synovial SarcomaKoji Uotani, Tomohiro Fujiwara, Aki Yoshida, et al.
Cancer Chemotherapy and Pharmacology|June 11, 2021
Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expressionKazuhisa Sugiu, Hiroshi Tazawa, Joe Hasei, et al.
Cancers|October 16, 2025
Utility of Same-Modality, Cross-Domain Transfer Learning for Malignant Bone Tumor Detection on Radiographs: A Multi-Faceted Performance Comparison with a Scratch-Trained ModelJoe Hasei, Ryuichi Nakahara, Yujiro Otsuka, et al.
Plos One|February 20, 2024
Fluorescence-guided assessment of bone and soft-tissue sarcomas for predicting the efficacy of telomerase-specific oncolytic adenovirusKoji Uotani, Hiroshi Tazawa, Joe Hasei, et al.
Pageof 4